Analysis of the key themes driving M&A activity reveals that artificial intelligence accounted for 6 pharmaceutical deals announced in Q2 2023, worth a total value of $191.2m. The $100m acquisition of DIA Imaging Analysis by Philips Healthcare UK was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q2 2023 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, artificial intelligence-related deal activity increased by 45% in Q2 2023 compared with the previous quarter’s total of $131.8m. Related deal volume increased by 50% in Q2 2023 versus the previous quarter and was 100% higher than in Q2 2022.
The top-ranked legal advisors supporting these M&A deals in Q2 2023 were Wilson Sonsini Goodrich & Rosati Professional; Gibson, Dunn & Crutcher; Gillespie Law Group with 2, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q2 2023 – Thematic Intelligence, buy the report here.